de la Camara R

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Spanjaart AM, Ljungman P, Tridello G, ..., Kersten MJ, Mielke S

Leukemia - (-) - [2024-07-23; online 2024-07-23]

Category: Rehabilitation Type: Journal article

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).

Worel N, Ljungman P, Verheggen ICM, ..., Kuball J, Ruggeri A

Bone Marrow Transplant - (-) - [2023-09-06; online 2023-09-06]

Category: Social Science & Humanities Type: Review

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT.

Ghorashian S, Malard F, Yüksel MK, ..., Ruggeri A, Chabannon C

Bone Marrow Transplant - (-) - [2021-11-20; online 2021-11-20]

Type: Other

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

Spanjaart AM, Ljungman P, de La Camara R, ..., Kersten MJ, Mielke S

Leukemia - (-) - [2021-11-08; online 2021-11-08]

Category: Health Type: Journal article